$CYH

Community Health Systems, Inc. (NYSE:CYH) Receives Consensus Rating of "Hold" from Analysts

Community Health Systems (NYSE:CYH) has received a consensus "Hold" rating from nine analysts, with an average 12-month price target of $3.6167. Analyst opinions are mixed, as some firms have upgraded the stock while others have downgraded it or cut price targets. Institutional investors hold approximately 84.99% of the company's shares.

Original reporting
MarketBeat · MarketBeat
Published Mar 26, 2026, 6:32 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 26, 2026, 7:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Community Health Systems, Inc. (NYSE:CYH) Receives Consensus Rating of "Hold" from Analysts — source image
Decision brief

The 30-second read

$CYHNeutralLow
01

Why it matters

The mixed analyst ratings suggest caution; no significant news indicates a wait-and-see approach.

02

Market read

The news has limited immediate trading impact but is relevant for long-term investors monitoring sector sentiment.

03

What to watch

Potential upcoming catalysts such as policy changes or healthcare reforms that could affect CYH.

Timing: long-term

Background

Community Health Systems is a major US healthcare provider with fluctuating investor sentiment.

Company-level read

Ticker impact

$CYHNeutralMedium confidence
Context

Primary focus of the news, relevant for healthcare sector investors.

Expected impact

Stable or slight decline in the near term, potential for sideways movement given mixed analyst opinions.

Evidence & confidence

The consensus 'Hold' rating and mixed analyst opinions suggest limited upside potential. Institutional ownership indicates stability but not necessarily growth. The price target is close to current levels, implying limited short-term movement.

Market effects

Healthcare sector remains cautious; no immediate sector-wide shifts expected.

Limited regional impact; news pertains primarily to US-based healthcare company.

Negligible; specific to US healthcare sector.

Counterpoint

Some analysts may see potential for undervaluation and a possible rebound if company fundamentals improve.

Key entities

  • Community Health Systems, Inc.

    A healthcare provider operating hospitals and clinics across the US.

  • Analysts

    Financial analysts providing ratings and price targets for CYH.

Related articles

$HCAMed

Uninsured patients rise sharply, hospitals report, citing Obamacare cuts | Chattanooga Times Free Press

More and more uninsured patients are showing up in hospital emergency rooms and clinics, having lost their coverage under the Affordable Care Act. Executives running some of the biggest hospital systems, including large for-profit chains spanning many states, expressed concern over the unexpectedly sharp rise in uninsured patients and the costs associated with treating them.

$CYHMed

Community Health Systems Stock Drops As Barclays Slashes Rating

Community Health Systems Inc. (NYSE: CYH) shares fell about 13.82% on July 23, 2026 after Barclays cut its rating to Underweight from Equal Weight and reaffirmed a $3 price target, citing weaker regulatory and reimbursement conditions for acute care hospitals. The article cites recent financials including $2.97B revenue and a $58M net loss for the quarter ended 2026/03/31.

$CYHMed

COMMUNITY HEALTH SYSTEMS INC (CYH): Results of Operations and Financial Condition

COMMUNITY HEALTH SYSTEMS INC (CYH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cyh-ex99_1.htm EX-99.1 EX-99.1 Exhibit Number 99.1 Investor Contact: Kevin Hammons Director and Chief Executive Officer (615) 465-7000 COMMUNITY HEALTH SYSTEMS, INC. ANNOUNCES SECOND QUARTER ENDED JUNE 30, 2026 RESULTS FRANKLIN, Tenn. (July 22, 2026) – Community Health

$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).